Lisa Hensley
#51,970
Most Influential Person Now
Microbiologist
Lisa Hensley 's AcademicInfluence.com Rankings
Lisa Hensley biology Degrees
Biology
#8320
World Rank
#11378
Historical Rank
#2317
USA Rank
Microbiology
#681
World Rank
#753
Historical Rank
#138
USA Rank
Download Badge
Biology
Lisa Hensley 's Degrees
- PhD Microbiology University of California, Berkeley
- Masters Biology Stanford University
- Bachelors Biotechnology University of California, Berkeley
Similar Degrees You Can Earn
Why Is Lisa Hensley Influential?
(Suggest an Edit or Addition)According to Wikipedia, Lisa Ellen Hensley is the associate director of science at the Office of the Chief Scientist, National Institute of Allergy and Infectious Disease Integrated Research Facility in Frederick, Maryland. She was previously a civilian microbiologist in the virology division of the United States Army Medical Research Institute of Infectious Diseases . Hensley is one of the premier researchers of some of the world's most dangerous infections, including Ebola hemorrhagic fever, Lassa fever, the coronavirus diseases Severe acute respiratory syndrome and Middle East respiratory syndrome , and smallpox. She has been involved in research uncovering critical mechanisms in the pathogenesis of hemorrhagic fever viruses, and has used those discoveries to develop candidate therapeutic drugs for their treatment.
Lisa Hensley 's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. (2019) (1061)
- Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses (2005) (626)
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection (2014) (579)
- Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. (2003) (553)
- Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo (2010) (485)
- Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study (2010) (430)
- Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia (2014) (412)
- Molecular Evidence of Sexual Transmission of Ebola Virus. (2015) (376)
- Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys (2003) (375)
- Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus (2003) (365)
- Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. (2003) (358)
- Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques (2012) (346)
- State of Knowledge and Data Gaps of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Humans (2013) (326)
- Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge (2014) (318)
- Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. (2003) (317)
- Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis (2014) (304)
- FDA-Approved Selective Estrogen Receptor Modulators Inhibit Ebola Virus Infection (2013) (301)
- Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses (2000) (300)
- Effective Post-Exposure Treatment of Ebola Infection (2007) (287)
- Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies (2007) (281)
- Evaluation of candidate vaccine approaches for MERS-CoV (2015) (275)
- Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone (2015) (262)
- Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. (2002) (254)
- Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference (2006) (244)
- Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus (2009) (244)
- Development of a New Vaccine for the Prevention of Lassa Fever (2005) (237)
- The Pathology of Experimental Aerosolized Monkeypox Virus Infection in Cynomolgus Monkeys (Macaca fascicularis) (2001) (231)
- A broad-spectrum antiviral targeting entry of enveloped viruses (2010) (223)
- Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus (2015) (207)
- A screen of approved drugs and molecular probes identifies therapeutics with anti–Ebola virus activity (2015) (206)
- CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates (2011) (199)
- Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol (2015) (199)
- Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. (2010) (197)
- Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2 (2020) (194)
- Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. (2014) (192)
- Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. (2008) (191)
- Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge (2011) (190)
- Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates (2008) (189)
- Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. (2015) (182)
- Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment (2006) (176)
- Phase 2 Placebo‐Controlled Trial of Two Vaccines to Prevent Ebola in Liberia (2017) (174)
- Interferon-β 1a and SARS Coronavirus Replication (2004) (168)
- Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox. (2004) (167)
- Depletion of peripheral blood T lymphocytes and NK cells during the course of ebola hemorrhagic Fever in cynomolgus macaques. (2004) (159)
- Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies (2017) (159)
- Genomic Variability of Monkeypox Virus among Humans, Democratic Republic of the Congo (2014) (155)
- Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. (2007) (153)
- Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates (2008) (147)
- Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions (2004) (138)
- Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. (2011) (134)
- Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples (2014) (129)
- Nonhuman Primates Are Protected from Smallpox Virus or Monkeypox Virus Challenges by the Antiviral Drug ST-246 (2009) (125)
- Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant Vaccine (2006) (124)
- Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2 (2007) (123)
- The pathogenesis of Rift Valley fever virus in the mouse model. (2010) (118)
- The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. (2004) (117)
- Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species (2010) (117)
- Real-Time Sequence-Validated Loop-Mediated Isothermal Amplification Assays for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) (2015) (113)
- Filoviruses Require Endosomal Cysteine Proteases for Entry but Exhibit Distinct Protease Preferences (2012) (108)
- Cynomolgus Macaque as an Animal Model for Severe Acute Respiratory Syndrome (2006) (107)
- Episodic evolution mediates interspecies transfer of a murine coronavirus (1997) (105)
- Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates (2012) (102)
- Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever. (2013) (101)
- Pathogenesis of lassa fever in cynomolgus macaques (2011) (97)
- Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae (2012) (97)
- Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo (2016) (95)
- Evolution and Spread of Ebola Virus in Liberia, 2014-2015. (2015) (95)
- ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification (2009) (93)
- Inhibition of heat-shock protein 90 reduces Ebola virus replication. (2010) (93)
- MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells (2018) (91)
- Lymphocyte death in a mouse model of Ebola virus infection. (2007) (90)
- Pathology of Experimental Aerosol Zaire Ebolavirus Infection in Rhesus Macaques (2013) (89)
- Formation of Antiviral Cytoplasmic Granules during Orthopoxvirus Infection (2010) (87)
- The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever (2007) (86)
- A Longitudinal Study of Ebola Sequelae in Liberia (2019) (85)
- The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection (2017) (83)
- Postexposure Treatment of Marburg Virus Infection (2010) (83)
- Middle East Respiratory Syndrome Coronavirus Infection in Dromedary Camels in Saudi Arabia (2014) (80)
- Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. (2011) (78)
- Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever (2010) (77)
- In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein. (2007) (77)
- Monitoring of Ebola Virus Makona Evolution through Establishment of Advanced Genomic Capability in Liberia (2015) (77)
- Evaluation of Lassa antiviral compound ST-193 in a guinea pig model (2011) (77)
- Capturing sequence diversity in metagenomes with comprehensive and scalable probe design (2019) (76)
- Evolution of Ebola Virus Disease from Exotic Infection to Global Health Priority, Liberia, Mid-2014 (2015) (73)
- Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates (2014) (72)
- Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA (2013) (71)
- 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012 (2016) (67)
- One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus (2016) (67)
- Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells. (2014) (65)
- Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time (2020) (65)
- Inactivation and safety testing of Middle East Respiratory Syndrome Coronavirus (2015) (65)
- Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. (2007) (63)
- Reduced evolutionary rate in reemerged Ebola virus transmission chains (2016) (61)
- Development of a Novel Nonhuman Primate Model for Rift Valley Fever (2011) (60)
- Ebola Virus Exploits a Monocyte Differentiation Program To Promote Its Entry (2013) (60)
- Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae (2013) (60)
- Ebola and Its Control in Liberia, 2014–2015 (2016) (60)
- Comparative Analysis of Viral Gene Expression Programs during Poxvirus Infection: A Transcriptional Map of the Vaccinia and Monkeypox Genomes (2008) (58)
- Stunned Silence: Gene Expression Programs in Human Cells Infected with Monkeypox or Vaccinia Virus (2011) (57)
- Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease (2015) (57)
- Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition (2010) (57)
- Using Remote Sensing to Map the Risk of Human Monkeypox Virus in the Congo Basin (2010) (57)
- In vivo Ebola virus infection leads to a strong innate response in circulating immune cells (2016) (55)
- Aerosol Exposure to Rift Valley Fever Virus Causes Earlier and More Severe Neuropathology in the Murine Model, which Has Important Implications for Therapeutic Development (2013) (55)
- A Novel Respiratory Model of Infection with Monkeypox Virus in Cynomolgus Macaques (2011) (54)
- Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. (2003) (54)
- FGI-104: a broad-spectrum small molecule inhibitor of viral infection. (2009) (54)
- Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names (2014) (53)
- Comparative pathology of smallpox and monkeypox in man and macaques. (2013) (52)
- Potential Vaccines and Post-Exposure Treatments for Filovirus Infections (2012) (52)
- Ebola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection (2017) (48)
- Ebola and Marburg viruses: pathogenesis and development of countermeasures. (2005) (48)
- Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication (2016) (48)
- Viral Hemorrhagic Fever Diagnostics. (2016) (48)
- Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures. (2018) (47)
- Single-Cell Profiling of Ebola Virus Disease In Vivo Reveals Viral and Host Dynamics (2020) (47)
- Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report. (2018) (46)
- Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection (2012) (45)
- Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report (2011) (45)
- Cellular immune response to Marburg virus infection in cynomolgus macaques. (2008) (44)
- Ebola Epidemic — Liberia, March–October 2014 (2014) (44)
- DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function. (2011) (41)
- Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation. (2011) (39)
- The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus. (2016) (39)
- The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates (2005) (38)
- The Master Regulator of the Cellular Stress Response (HSF1) Is Critical for Orthopoxvirus Infection (2014) (38)
- Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo (2017) (37)
- Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus. (2011) (35)
- Detailed Analysis of the African Green Monkey Model of Nipah Virus Disease (2015) (35)
- Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2 (2020) (35)
- Pathogenic hantaviruses elicit different immunoreactions in THP-1 cells and primary monocytes and induce differentiation of human monocytes to dendritic-like cells. (2007) (34)
- Modeling [18F]-FDG lymphoid tissue kinetics to characterize nonhuman primate immune response to Middle East respiratory syndrome-coronavirus aerosol challenge (2015) (34)
- CD26/DPP4 Cell-Surface Expression in Bat Cells Correlates with Bat Cell Susceptibility to Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Evolution of Persistent Infection (2014) (34)
- Emerging Disease or Diagnosis? (2012) (34)
- Transcriptional Profiling of the Circulating Immune Response to Lassa Virus in an Aerosol Model of Exposure (2013) (33)
- Countermeasures to the bioterrorist threat of smallpox. (2005) (33)
- Progression of Pathogenic Events in Cynomolgus Macaques Infected with Variola Virus (2011) (33)
- Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin (2019) (33)
- Transcriptional Profiling of the Immune Response to Marburg Virus Infection (2015) (32)
- Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs (2018) (32)
- Cytokine modulation correlates with severity of monkeypox disease in humans (2014) (31)
- Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease (2015) (31)
- Ultrastructural study of Rift Valley fever virus in the mouse model. (2012) (30)
- Pathogen-Host Associations and Predicted Range Shifts of Human Monkeypox in Response to Climate Change in Central Africa (2013) (30)
- Nonhuman Primate Models of Ebola Virus Disease. (2017) (29)
- Necrotizing Scleritis, Conjunctivitis, and Other Pathologic Findings in the Left Eye and Brain of an Ebola Virus-Infected Rhesus Macaque (Macaca mulatta) With Apparent Recovery and a Delayed Time of Death. (2016) (29)
- Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections. (2002) (29)
- Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection (2014) (29)
- The Calcium Channel Blocker Bepridil Demonstrates Efficacy in the Murine Model of Marburg Virus Disease. (2018) (28)
- Evaluation of the Activity of Lamivudine and Zidovudine against Ebola Virus (2016) (26)
- Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression (2011) (24)
- Transcriptional Correlates of Disease Outcome in Anticoagulant-Treated Non-Human Primates Infected with Ebolavirus (2014) (23)
- In vitro inhibition of monkeypox virus production and spread by Interferon-β (2012) (23)
- Temporal Characterization of Marburg Virus Angola Infection following Aerosol Challenge in Rhesus Macaques (2015) (21)
- Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates (2018) (21)
- How NETosis could drive “Post-COVID-19 syndrome” among survivors (2020) (21)
- High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona (2017) (21)
- Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach. (2013) (21)
- Simplified Cas13-based assays for the fast identification of SARS-CoV-2 and its variants (2022) (20)
- Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans (2018) (19)
- Ebola Virus Transmission Initiated by Systemic Ebola Virus Disease Relapse (2021) (19)
- Interferon-b and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays (2014) (18)
- Use of Existing Diagnostic Reverse-Transcription Polymerase Chain Reaction Assays for Detection of Ebola Virus RNA in Semen. (2016) (18)
- Use of the Filovirus Animal Non-Clinical Group (FANG) Ebola virus immuno-assay requires fewer study participants to power a study than the Alpha Diagnostic International assay (2018) (18)
- Natural History of Aerosol Exposure with Marburg Virus in Rhesus Macaques (2016) (18)
- In Vitro and In Vivo Activity of Amiodarone Against Ebola Virus. (2018) (18)
- Chikungunya and O’nyong-nyong Viruses in Uganda: Implications for Diagnostics (2019) (17)
- New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model. (2018) (17)
- Pathology of Experimental Machupo Virus Infection, Chicava Strain, in Cynomolgus Macaques (Macaca fascicularis) by Intramuscular and Aerosol Exposure (2015) (17)
- Virus-receptor interactions and interspecies transfer of a mouse hepatitis virus. (1998) (17)
- Infection of cynomolgus macaques with a recombinant monkeypox virus encoding green fluorescent protein (2011) (16)
- Lack of Effect of Lamivudine on Ebola Virus Replication (2015) (15)
- Detection and identification of Variola virus in fixed human tissue after prolonged archival storage (2004) (15)
- PREVAIL IV: A Randomized, Double-Blind, Two-Phase, Phase 2 Trial of Remdesivir versus Placebo for Reduction of Ebola Virus RNA in the Semen of Male Survivors. (2021) (15)
- In Vivo Activity of Amodiaquine against Ebola Virus Infection (2019) (15)
- Assessment and Optimization of the GeneXpert Diagnostic Platform for Detection of Ebola Virus RNA in Seminal Fluid (2016) (15)
- Repurposing of clinically developed drugs for treatment of Middle East Respiratory Coronavirus 1 Infection (2014) (15)
- Filovirus Pathogenesis in Nonhuman Primates (2002) (15)
- The NIAID Integrated Research Facility at Frederick, Maryland: a unique international resource to facilitate medical countermeasure development for BSL‐4 pathogens (2014) (15)
- Identification of a Pyridopyrimidinone Inhibitor of Orthopoxviruses from a Diversity-Oriented Synthesis Library (2011) (15)
- The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses (2020) (14)
- Fully Human Immunoglobulin G From Transchromosomic Bovines Treats Nonhuman Primates Infected With Ebola Virus Makona Isolate (2018) (14)
- Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques (2020) (13)
- Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples (2019) (12)
- PREVAIL I Cluster Vaccination Study With rVSV&Dgr;G-ZEBOV-GP as Part of a Public Health Response in Liberia (2019) (12)
- State-of-the-Art Workshops on Medical Countermeasures Potentially Available for Human Use Following Accidental Exposures to Ebola Virus. (2015) (12)
- Full-Genome Sequence of Human Betacoronavirus 2c Jordan-N3/2012 after Serial Passage in Mammalian Cells (2014) (11)
- Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo (2021) (11)
- Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak. (2017) (11)
- Detecting pathogen exposure during the non-symptomatic incubation period using physiological data (2017) (10)
- Viral hemorrhagic fevers. (1990) (9)
- Natural History of Aerosol Induced Lassa Fever in Non-Human Primates (2020) (9)
- Human biliary glycoproteins function as receptors for interspecies transfer of mouse hepatitis virus. (1998) (9)
- Genome Sequence of Bivens Arm Virus, a Tibrovirus Belonging to the Species Tibrogargan virus (Mononegavirales: Rhabdoviridae) (2015) (8)
- Capturing diverse microbial sequence with comprehensive and scalable probe design (2018) (8)
- Effective Post-Exposure Treatment of Ebola (2007) (8)
- High depth, whole-genome sequencing of cholera isolates from Haiti and the Dominican Republic (2012) (8)
- Receptor homologue scanning functions in the maintenance of MHV-A59 persistence in vitro. (1998) (8)
- Equipment-free detection of SARS-CoV-2 and Variants of Concern using Cas13 (2021) (8)
- Interferon-&bgr; and Interferon-&ggr; Are Weak Inhibitors of Ebola Virus in Cell-Based Assays (2017) (8)
- Enhancing laboratory capacity during Ebola virus disease (EVD) heightened surveillance in Liberia: lessons learned and recommendations (2019) (7)
- Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures. (2016) (7)
- Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal Model (2020) (7)
- Deep Learning for Automated Liver Segmentation to Aid in the Study of Infectious Diseases in Nonhuman Primates. (2020) (6)
- Ebola Virus Isolation Using Huh-7 Cells has Methodological Advantages and Similar Sensitivity to Isolation Using Other Cell Types and Suckling BALB/c Laboratory Mice (2019) (6)
- The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection. (2018) (6)
- Single-cell profiling of Ebola virus infection in vivo reveals viral and host transcriptional dynamics (2020) (6)
- Nonhuman Transferrin Receptor 1 Is an Efficient Cell Entry Receptor for Ocozocoautla de Espinosa Virus (2013) (6)
- Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae (2010) (5)
- The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps (2022) (5)
- An introduction to the Marburg virus vaccine consortium, MARVAC (2022) (5)
- Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors (2021) (4)
- Systems kinomics for characterizing host responses to high‐consequence pathogens at the NIH/NIAID Integrated Research Facility‐Frederick (2014) (4)
- Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the Congo (2022) (4)
- Association of Lower Exposure Risk With Paucisymptomatic/Asymptomatic Infection, Less Severe Disease, and Unrecognized Ebola Virus Disease: A Seroepidemiological Study (2022) (4)
- Effect of Monkeypox Virus Preparation on the Lethality of the Intravenous Cynomolgus Macaque Model (2022) (4)
- Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII Study (2021) (4)
- Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology. (2016) (4)
- Rhesus Macaque CODEX Multiplexed Immunohistochemistry Panel for Studying Immune Responses During Ebola Infection (2021) (4)
- Filoviruses infect rhesus macaque synoviocytes in vivo and primary human synoviocytes in vitro. (2020) (4)
- Peripheral Neuronopathy Associated with Ebola virus infection in Rhesus Macaques: A Possible Cause of Neurological Signs and Symptoms in Human Ebola Patients. (2020) (3)
- Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae (2012) (3)
- Quantification of axillary lymphadenopathy from CT images of filovirus infections in non-human primates: sensitivity and evaluation of radiomics-based methods (2020) (3)
- Probing the virus host interaction in high containment: an approach using pooled short hairpin RNA. (2015) (3)
- Hexamminecobalt (III) Chloride as a Broad-Spectrum Antiviral Complex (2011) (3)
- Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA (2013) (2)
- SARS-CoV-2 Sequence Analysis during COVID-19 Case Surge, Liberia, 2021 (2021) (2)
- Detecting Pathogen Exposure During the Non-symptomatic Incubation Period Using Physiological Data: Proof of Concept in Non-human Primates (2021) (2)
- Assessment of High-Throughput Screening (HTS) Methods for High-Consequence Pathogens (2011) (2)
- Evaluation of R2* as a noninvasive endogenous imaging biomarker for Ebola virus liver disease progression in nonhuman primates (2020) (2)
- Expanded Histopathology and Tropism of Ebola Virus in the Rhesus Macaque Model: Potential for Sexual Transmission, Altered Adrenomedullary Hormone Production and Early Viral Replication in liver. (2021) (2)
- Virus Adaptation and Treatment (2010) (2)
- Evaluation of Virulence in Cynomolgus Macaques Using a Virus Preparation Enriched for the Extracellular Form of Monkeypox Virus (2022) (1)
- Increased Likelihood of Detecting Ebola Virus RNA in Semen by Using Sample Pelleting (2021) (1)
- Lassa and Marburg viruses elicit distinct host transcriptional responses early after infection (2014) (1)
- Detecting Virus Exposure During the Pre Symptomatic Incubation Period Using Physiological Data (with Supplementary Materials) (2016) (1)
- Postexposure Treatment of (2010) (1)
- Detailed analysis of the pathologic hallmarks of Nipah virus (Malaysia) disease in the African green monkey infected by the intratracheal route (2022) (1)
- Title: Development of a Novel Non-human Primate Model for Rift Valley Fever (2011) (1)
- Experiences of outbreak laboratory management in the Ebola Disease outbreak in West-Africa 2014-2015 (Forthcoming) (2016) (1)
- In vitro inhibition of monkeypox virus production and spread by Interferon-β (2012) (1)
- Ebola virus is unlikely to become endemic in West Africa (2016) (1)
- High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona (2017) (0)
- Pathogenesis of Ebola Virus Infection in Nonhuman Primates (2003) (0)
- Cocktail party: Low-dose antibody combinations deliver pan-ebolavirus protection (2022) (0)
- In vivo single-cell profiling of lncRNAs during Ebola virus infection (2022) (0)
- 996. Development of an siRNA Based Therapy for Ebola Virus Infection (2005) (0)
- Infectious NiV in Throat, Nasal, and Rectal Swab Samples. (2015) (0)
- Longitudinal analyses using 18F-Fluorodeoxyglucose positron emission tomography with computed tomography as a measure of COVID-19 severity in the aged, young, and humanized ACE2 SARS-CoV-2 hamster models (2023) (0)
- Hantaviruses cause cytopathic effect in continuous human embryonic kidney 293 cell line (2002) (0)
- Potential Ebola therapies identifi ed using high throughput phenotypic screening of drugs and combinations (2013) (0)
- Computed Tomography Imaging for Monitoring of Marburg Virus Disease: a Nonhuman Primate Proof-Of-Concept Study (2023) (0)
- Correction for Olsen et al., “Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication” (2018) (0)
- Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae (2013) (0)
- Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report (2022) (0)
- Chikungunya in Uganda: Sometimes the Hoof Beats Really Are Zebras (2017) (0)
- Development and Clinical Evaluation of a Rapid Point of Care Test for Ebola Virus Infection in Humans (2023) (0)
- Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection (2020) (0)
- Errata (2014) (0)
- The role of monocytes/macrophages in immunopathogenesis of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome (2002) (0)
- Diversity-Oriented Synthesis Library Inhibitor of Orthopoxviruses from a Identification of a Pyridopyrimidinone (2012) (0)
- In vivo Ebola virus infection leads to a strong innate response in circulating immune cells (2016) (0)
- The Antiviral Potential of ERK / MAPK and PI 3 K / AKT / mTOR Signaling Modulation 1 for MERS-CoV Infection as Identified by Temporal Kinome Analysis 2 3 4 Running Title : Kinome analysis of MERS-CoV infection 5 6 (2014) (0)
- Small Molecule Therapeutics of Viruses of Families Bunyaviridae and Arenaviridae (2010) (0)
- Viral RNA in PBMC and throat, nasal, and rectal swabs as measured by qRT-PCR. (2015) (0)
- Short Communication Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells (2003) (0)
This paper list is powered by the following services:
Other Resources About Lisa Hensley
What Schools Are Affiliated With Lisa Hensley ?
Lisa Hensley is affiliated with the following schools:
